Hyperimmune Colostrum and Oral Mucositis
Head and Neck Cancer
Conditions: official terms
Head and Neck Neoplasms - Mucositis - Stomatitis
Conditions: Keywords
hyperimmune colostrum, mucositis
Study Type
Study Phase
Study Design
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Supportive Care
Name: hyperimmune colostrum Type: Dietary Supplement
Name: Placebo Type: Dietary Supplement
Overall Status
Not yet recruiting
To study the effect of daily intake of hyperimmune colostrum on prevention and treatment of oral mucositis in patients with head and neck cancer undergoing high-dose radiation.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- Patients with: naso-pharynx, oral cavity, oro-pharynx and advanced localized laryngeal cancer.

Exclusion Criteria:

- Other tumors

- Non-epithelial tumors

- Pregnancy

- Poor functional status
Sourasky Medical Center
Tel-Aviv, Israel
Status: Not yet recruiting
Contact: Nachum Vaisman, Prof' - 972-3-697-4807 - vaisman@tasmc.health.gov.il
Start Date
July 2008
Completion Date
July 2009
Tel-Aviv Sourasky Medical Center
Tel-Aviv Sourasky Medical Center
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page